3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Colon Neoplasms: new trials by email Literature Review of Colon Neoplasms trials Research Report on Colon Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cancer Vaccine Targeting Brachyury Protein in Tumors GI-6301 (Yeast Brachyury Vaccine) - Neoplasms, Malignant Solid Tumors | Phase 1 | Completed | National Cancer Institute (NCI) | 34 | 2012-01-05 | 2018-01-29 |
| AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer Cetuximab, AZD6244 - Colonic Neoplasms, Cancer of the Colon | Phase 1 | Completed | National Cancer Institute (NCI) | 10 | 2011-01-07 | 2019-12-17 |
| A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) AZD6244, Dacarbazine, Erlotinib - Breast Cancer, Breast Neoplasms | Phase 1 | Completed | AstraZeneca | 140 | 2007-12-14 | 2026-05-27 |
Colonic Neoplasms (3) · Neoplasms (2) · Adenocarcinoma (1) · Breast Neoplasms (1) · Colorectal Neoplasms (1) · Kidney Neoplasms (1) · Lung Neoplasms (1) · Melanoma (1)
Colonic Diseases (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Intestinal Diseases (3) · Intestinal Neoplasms (3) · Neoplasms by Site (3) · Colorectal Neoplasms (2) · Neoplasms by Histologic Type (2) · Breast Diseases (1) · Carcinoma (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1)
AZD 6244 (2) · Cetuximab (1) · Dacarbazine (1) · Docetaxel (1) · Erlotinib Hydrochloride (1) · temsirolimus (1)
National Cancer Institute (NCI) (2) · AstraZeneca (1)
United States (3)
Austin G Duffy, M.D. (1) · James L Gulley, M.D. (1) · Jeffrey Infante, MD (1) · Kevin Kim, MD (1) · Patricia LoRusso, DO (1) · Roger Cohen, MD (1)
PMID 22972589, PMID 26130065, PMID 26596767, PMID 26666244, PMID 28264648, PMID 28424891